HomeClinical TopicsFDA approves Elelyso for Gaucher disease

FDA approves Elelyso for Gaucher disease

On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content